Afuco™ Anti-Human MFAP4 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-MFAP4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibody that binds MFAP4 expressed on the surface of a subset of regulatory cells and anti-cancer cells. The activated regulatory cells can be used to treat or prevent the progression of many types of immune-related diseases, such as graft rejection, graft-versus-host disease, autoimmune disease, allergic diseases and infectious disease. The activated anti-cancer cells can be used to treat or prevent the progression of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-502CL |
| Pricing | Inquiry |
| Host | Human |
| Target | MFAP4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Can be stored at 4°C. For long term storage, aliquot and store at -20°C. Avoid repeated freezing and thawing cycles. |